|
|
||||||||
ORIGINAL RESEARCH |
From the Departments of Obstetrics and Gynecology and Medical Biostatistics, University of Vermont College of Medicine, Burlington, Vermont.
Address reprint requests to: Ira M. Bernstein, MDDepartment of Obstetrics and Gynecology Shepardson 331, F.A.H.C.111 Colchester Avenue Burlington, VT 05401-1435 E-mail: ibernste{at}zoo.uvm.edu
| Abstract |
|---|
|
|
|---|
Methods: We prospectively measured plasma volume by Evans blue dye dilution during the menstrual (cycle day 23), follicular (cycle day 910), and luteal phases (cycle day urinary leutinizing hormone [LH] surge plus 910) of the menstrual cycle and at three additional time points (LH surge + 16 days, LH surge + 28 days, and LH surge + 70 days) in women achieving pregnancy. Twenty-one subjects were examined during 38 menstrual cycles to establish baseline menstrual cycle data. Ten subjects conceived within 1 year of menstrual cycle studies. All ten pregnancies were viable and reached the third trimester. Analyses used repeated-measures analysis of variance with P < .05 accepted for significance.
Results: Mean plasma volume was found to change significantly across the period of observation (P < .008) in those who conceived. Plasma volume at LH surge + 70 days (12 menstrual weeks, 2320 ± 280 mL) was greater than either menstrual cycle estimates or early pregnancy estimates of plasma volume. There was no difference in plasma volume at LH surge + 16 days (2077 ± 288 mL) or LH surge + 28 days (2010 ± 271 mL) compared with menstrual cycle measurements during the menstrual phase (2156 ± 292 mL), follicular phase (2036 ± 280 mL), and luteal phase (2120 ± 425 mL). There was no significant difference between those who conceived and those who did not in their mean menstrual cycle plasma volume.
Conclusion: Plasma volume expansion in early human pregnancy cannot be identified until after the sixth menstrual week. By 12 menstrual weeks, plasma volume has expanded by approximately 14% ± 12% (mean ± SD) over follicular phase measurements.
Inadequate plasma volume expansion in pregnancy has been linked with poor reproductive performance. Specifically, both fetal growth restriction and preeclampsia are associated with reduced plasma volume during pregnancy.14 We recently demonstrated that women who carry a genetic predisposition to preeclampsia have a reduced plasma volume before becoming pregnant.5 Others have suggested that reduced nonpregnant plasma volume may be linked to fetal growth restriction.6 We sought to determine the timing of the onset of plasma volume expansion through the menstrual cycle into pregnancy in order to clarify the physiologic sequence of plasma volume expansion before conception and into the first trimester of pregnancy. We also sought to examine if reduced plasma volume before conception contributes to infertility.
| Materials and Methods |
|---|
|
|
|---|
Women were provided with 12 months of urinary LH detection kits to assist in achieving pregnancy. Ten conceived without further assistance during this 12-month time. All pregnancies were viable and were maintained into the third trimester. There were nine singleton pregnancies and one twin gestation. The pattern and extent of plasma volume expansion for the twin pregnancy did not differ from the singleton pregnancies through 12 weeks of gestation and it was included in the overall analysis.
For each plasma volume estimate, all subjects were admitted to the University of Vermont General Clinical Research Center after a 12-hour overnight fast. Vital signs were measured after 15 minutes of rest in the supine position. A single saline lock was initiated and baseline values for dye dilution were obtained. A dose of Evans blue dye (15 mg) in a preweighed syringe was administered through the saline lock over 60 seconds. The Evans blue was prepared as a batched sample for this project, assuring a consistent concentration. Dosing, sample preparation, and analysis have been described previously.5,7,8 The mean within-individual coefficient of variation for the estimation of plasma volume for a single study using this technique was less than 1.0%.
We reported previously the follicular phase plasma volumes for 15 of these women in an examination of the relationship between nonpregnant plasma volume and angiotensinogen M235T genotype.5 Subjects signed informed written consent and this study was approved by the University of Vermont Committee on Human Research in the Medical Sciences.
Statistical analysis was performed using repeated-measures analyses of variance. Fishers least significant difference test was used to perform pair-wise comparisons. Multiple cycles within an individual were not considered independent observations and were treated as being nested within subject. Demographic characteristics compared between women who conceived and nonconceiving women were compared using t tests. Statistical significance was determined based on P < .05.
| Results |
|---|
|
|
|---|
|
We also examined the pattern of plasma volume change over the course of the menstrual cycle in the 21 subjects examining nonconception cycles. We combined nonconception cycle data from women who conceived with those who did not. We found a significant increase in the mean plasma volume during menses (2258 ± 346 mL, mean ± SD) compared with either the midfollicular (2134 ± 328 mL) or midluteal (2146 ± 369 mL) measurements (P < .05). There was no difference between the midfollicular and midluteal estimate of plasma volume. There were no overall differences across subjects who eventually conceived compared with those who did not, nor was the pattern across the menstrual cycle different for the two groups (Table 2
). Additionally, there was no evidence for an interaction between the pattern of plasma volume through the menstrual cycle and conception. We further compared estimates of plasma volume, corrected for body size by dividing by body mass index, during the menstrual cycle between subjects who conceived and those who did not. Again, we found no significant difference between these groups at all phases of the menstrual cycle, or in the trend over time during the menstrual cycle.
|
| Discussion |
|---|
|
|
|---|
These findings are consistent with a placental signal playing a primary role in the first trimester plasma volume expansion as the time course of plasma volume expansion overlaps with the luteoplacental shift.11 Although the placental signal sequence responsible for plasma volume expansion remains uncertain, Longo12 summarized evidence suggesting that placental estrogen may well be the primary signal.
We found a significant increase in the estimation of plasma volume during menses in women experiencing regular ovulatory menstrual cycles when nonconception cycles from all 21 subjects were combined. This finding is consistent with publications regarding plasma volume measured by indirect techniques.13,14 Using changes in hemoglobin and hematocrit levels as indirect measures of changes in plasma volume, these two studies demonstrated that menstrual estimates of plasma volume exceed those of the midfollicular phase.13,14 Luteal phase plasma volume estimates have varied more widely. We did not detect a difference between luteal and follicular phase estimates consistent with the findings of Cullinane et al,13 who estimated plasma volume on days 20 and 25 of the cycle. Pahwa et al14 suggested that plasma volume increased slightly when estimates were made at a similar time (days 2224 of the menstrual cycle) in a group of slightly younger women, aged 1722 years. The course of plasma volume during the luteal phase of the menstrual cycle is therefore less clear and may be more variable. Our data do not exclude the possibility that a late luteal expansion of the plasma volume is detected with our midmenses assessments.
While it is clear that reduced plasma volume is associated with abnormal pregnancy outcome,14,6 we were unable to identify any information in the literature (MEDLINE search terms: infertility, blood volume, plasma volume, 19662000) regarding the association of plasma volume and fertility. In this study, we compared the plasma volume estimates across the menstrual cycle between women achieving spontaneous conception within 1 year of initiating attempts and those who did not conceive. We found no differences between these groups in comparing any phase of the menstrual cycle or in the pattern of plasma volume adaptation over the course of the menstrual cycle. There was a tendency for women who did not conceive to have higher estimates of plasma volume, even when corrected for their size. Although this study did not have sufficient power to conclusively identify the lack of a relationship between plasma volume constriction and infertility, the results suggest that it is unlikely to be a major factor.
| Footnotes |
|---|
Received August 16, 2000. Received in revised form November 18, 2000. Accepted December 7, 2000.
| References |
|---|
|
|
|---|
2. Soffronoff EC, Kaufmann BM, Connaughton JF. Intravascular volume determinations and fetal outcomes in hypertensive diseases of pregnancy. Am J Obstet Gynecol 1977;127:49.[Medline]
3. Salas SP, Rosso P, Espinoza R, Robert JA, Valdes G, Donoso E. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol 1993;81:102933.
4. Duvekot JJ, Cheriex EC, Pieters FAA, Menherre PPCA, Schouten HJA, Peeters LLH. Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction. Obstet Gynecol 1995;85:3617.[Abstract]
5. Bernstein IM, Ziegler W, Stirewalt WS, Brumsted J, Ward K. Angiotensinogen genotype and plasma volume in nulligravid women. Obstet Gynecol 1998;92:1713.[Abstract]
6. Croall J, Sherrif S, Matthews J. Non-pregnant maternal plasma volume and fetal growth retardation. Br J Obstet Gynaecol 1978; 85:905.[Medline]
7. Greenleaf JE, Convertino VA, Mangseth GR. Plasma volume during stress in man: Osmolality and red cell volume. J Appl Physiol 1979;47:10318.
8. El-Sayed H, Goodal SR, Hainsworth R. Re-evaluation of Evans blue dye dilution method of plasma volume measurement. Clin Lab Haematol 1995;17:18994.[Medline]
9. Whitaker PG. The intravascular mass of albumin during human pregnancy: A serial study in normal and diabetic women. Br J Obstet Gynaecol 1993;100:58792.[Medline]
10. Lund CJ, Donovan JC. Blood volume during pregnancy. Am J Obstet Gynecol 1967;98:393403.
11. Csapo AI, Pulkkinen MO, Wiest WG. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. Am J Obstet Gynecol 1973;115:75965.[Medline]
12. Longo L. Maternal blood volume and cardiac output during pregnancy: A hypothesis of endocrinologic control. Am J Physiol 1983;245:R7209.[Medline]
13. Cullinane EM, Yurgalevitch SM, Saritelli AL, Herbert PN, Thompson PD. Variations in plasma volume affect total and low-density lipoprotein cholesterol concentrations during the menstrual cycle. Metabolism 1995;44:96571.[Medline]
14. Pahwa MB, Seth S, Seth RK. Lipid profile in various phases of the menstrual cycle and its relationship with percentage plasma volume changes. Clin Chim Acta 1998;273:2017.[Medline]
This article has been cited by other articles:
![]() |
R. Aardenburg, M. E. Spaanderman, H. W. van Eijndhoven, P. W. de Leeuw, and L. L. Peeters A Low Plasma Volume in Formerly Preeclamptic Women Predisposes to the Recurrence of Hypertensive Complications in the Next Pregnancy Reproductive Sciences, December 1, 2006; 13(8): 598 - 603. [Abstract] [PDF] |
||||
![]() |
D. P. Damron, B. A. Bouchard, R. E. Shapiro, A. L. Schonberg, and I. M. Bernstein Platelet Activation, Sympathetic Tone, and Plasma Volume in Nulligravid Women of Reproductive Age Obstet. Gynecol., May 1, 2004; 103(5): 931 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Hladunewich, R. A. Lafayette, G. C. Derby, K. L. Blouch, J. W. Bialek, M. L. Druzin, W. M. Deen, and B. D. Myers The dynamics of glomerular filtration in the puerperium Am J Physiol Renal Physiol, March 1, 2004; 286(3): F496 - F503. [Abstract] [Full Text] |
||||
![]() |
I. M. Bernstein, W. F. Ziegler, T. Leavitt, and G. J. Badger Uterine Artery Hemodynamic Adaptations Through the Menstrual Cycle Into Early Pregnancy Obstet. Gynecol., April 1, 2002; 99(4): 620 - 624. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |